• Mon, February 12, 2024

by: WOPRAI

Ygal Arounian Maintained (VRSN) at Strong Buy with Decreased Target to $237 on, Feb 12th, 2024

by: WOPRAI

Yi Fu Lee Maintained (ZS) at Hold with Increased Target to $250 on, Feb 12th, 2024

by: WOPRAI

Matt Miksic Maintained (ZBH) at Sell with Increased Target to $130 on, Feb 12th, 2024

by: WOPRAI

Luke Sergott Maintained (WAT) at Sell with Increased Target to $300 on, Feb 12th, 2024

by: WOPRAI

Ramsey El-Assal Maintained (WEX) at Buy with Increased Target to $255 on, Feb 12th, 2024

by: WOPRAI

RJ Milligan Downgraded (WPC) to Hold on, Feb 12th, 2024

by: WOPRAI

Brad Heffern Maintained (WPC) at Buy with Decreased Target to $65 on, Feb 12th, 2024

by: WOPRAI

Rupesh Parikh Maintained (WMT) at Buy with Increased Target to $62 on, Feb 12th, 2024

by: WOPRAI

Jay McCanless Maintained (BLDR) at Buy with Increased Target to $225 on, Feb 12th, 2024

by: WOPRAI

Andrew Schmitt Maintained (BILL) at Strong Buy with Decreased Target to $120 on, Feb 12th, 2024

by: WOPRAI

Geoffrey Kwan Maintained (BN) at Buy with Increased Target to $53 on, Feb 12th, 2024

by: WOPRAI

C J Muse Reiterated (AMD) at Buy and Held Target at $190 on, Feb 12th, 2024

by: WOPRAI

Olivia Brayer Reiterated (ALNY) at Hold and Held Target at $165 on, Feb 12th, 2024

by: WOPRAI

Brian Meredith Maintained (ALL) at Strong Buy with Increased Target to $185 on, Feb 12th, 2024

by: WOPRAI

Thomas Yeh Maintained (AMCX) at Sell with Decreased Target to $11 on, Feb 12th, 2024

by: WOPRAI

Craig Ellis Maintained (AMAT) at Strong Buy with Increased Target to $220 on, Feb 12th, 2024

by: WOPRAI

Joseph Moore Maintained (AMAT) at Hold with Increased Target to $190 on, Feb 12th, 2024

by: WOPRAI

C J Muse Reiterated (AMAT) at Hold and Held Target at $180 on, Feb 12th, 2024

by: WOPRAI

John Nadel Maintained (AIZ) at Strong Buy with Increased Target to $205 on, Feb 12th, 2024

by: WOPRAI

Thomas McJoynt-Griffith Downgraded (AIZ) to Hold and Increased Target to $182 on, Feb 12th, 2024

by: WOPRAI

Matt Miksic Maintained (BAX) at Buy with Increased Target to $54 on, Feb 12th, 2024

by: WOPRAI

Seth Sigman Maintained (AZO) at Buy on, Feb 12th, 2024

by: WOPRAI

Etzer Darout Maintained (AZN) at Buy with Decreased Target to $80 on, Feb 12th, 2024

by: WOPRAI

James Fotheringham Maintained (AFRM) at Hold with Increased Target to $47 on, Feb 12th, 2024

by: WOPRAI

C J Muse Reiterated (ADI) at Hold and Held Target at $205 on, Feb 12th, 2024

by: WOPRAI

Roy Buchanan Downgraded (ANTX) to Hold on, Feb 12th, 2024

by: WOPRAI

Jeff Jones Downgraded (ANTX) to Hold on, Feb 12th, 2024

by: WOPRAI

Liisa Bayko Downgraded (ANTX) to Hold and Decreased Target to $7 on, Feb 12th, 2024

by: WOPRAI

Paul Newsome Maintained (AON) at Hold with Increased Target to $326 on, Feb 12th, 2024

by: WOPRAI

Gil Blum Maintained (AUTL) at Strong Buy with Increased Target to $9 on, Feb 12th, 2024

by: WOPRAI

C J Muse Reiterated (AVGO) at Buy with Increased Target to $130 on, Feb 12th, 2024

by: WOPRAI

Emily Bodnar Initiated (ATOS) at Strong Buy and Held Target at $4 on, Feb 12th, 2024

by: WOPRAI

Kannan Venkateshwar Maintained (BCE) at Hold with Decreased Target to $52 on, Feb 12th, 2024

by: WOPRAI

Mark Strouse Downgraded (BEP) to Hold and Decreased Target to $28 on, Feb 12th, 2024

by: WOPRAI

Michael Leithead Maintained (BERY) at Hold with Decreased Target to $64 on, Feb 12th, 2024

by: WOPRAI

Frank Schiraldi Upgraded (CASS) to Buy and Increased Target to $51 on, Feb 12th, 2024

by: WOPRAI

Timothy Thein Maintained (CAT) at Hold with Increased Target to $340 on, Feb 12th, 2024

by: WOPRAI

Joseph Stauff Downgraded (BYD) to Hold and Decreased Target to $75 on, Feb 12th, 2024

by: WOPRAI

Ruben Roy Upgraded (VIAV) to Strong Buy and Increased Target to $13 on, Feb 12th, 2024

by: WOPRAI

Etienne Ricard Maintained (VCTR) at Buy with Increased Target to $51 on, Feb 12th, 2024

by: WOPRAI

Michael Cyprys Maintained (VCTR) at Sell with Increased Target to $30 on, Feb 12th, 2024

by: WOPRAI

Marina Calero Reiterated (VALE) at Buy and Held Target at $19 on, Feb 12th, 2024

by: WOPRAI

Chris Shibutani Upgraded (UTHR) to Hold and Increased Target to $215 on, Feb 12th, 2024

by: WOPRAI

Aaron Kessler Initiated (TTD) at Hold on, Feb 12th, 2024

by: WOPRAI

Tim Casey Maintained (TU) at Buy with Decreased Target to $26 on, Feb 12th, 2024

by: WOPRAI

C J Muse Reiterated (TXN) at Hold and Held Target at $170 on, Feb 12th, 2024

by: WOPRAI

Tim Nollen Downgraded (U) to Sell and Held Target at $20 on, Feb 12th, 2024

by: WOPRAI

Kenneth Lee Maintained (ARES) at Buy with Increased Target to $145 on, Feb 12th, 2024

Roy Buchanan Downgraded (ANTX) to Hold on, Feb 12th, 2024

Roy Buchanan of JMP Securities, Downgraded "AN2 Therapeutics, Inc." (ANTX) to Hold on, Feb 12th, 2024.

Roy, nor any peers, have made any analyst calls on ANTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍